ClinicalTrials.gg
CompletedNCT06473688NESTUpdated Nov 17, 2026

The DEXTER-assisted Non-Emergent and Acute cholecyStecTomy Study (The NEST Study)

An observational study in Cholecystectomy, sponsored by Distalmotion SA. Completed at 4 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Distalmotion SA · Observational

How we know

Updated Nov 17, 2026Results publication addedSponsor changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
51
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted and laparoscopic cholecystectomy.

02

Conditions studied

  • Cholecystectomy
03

In context

Lead sponsor

Distalmotion SA is the lead sponsor of 9 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients undergoing a cholecystectomy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged > 18 years
  • Patients planned to undergo elective robot-assisted and laparoscopic cholecystectomy; using one camera port, two ports for the manipulating instruments, and additional ports as needed.

Exclusion criteria

Exclusion Criteria:

  • Morbidly obese patients ( > 40)
  • Any relative and absolute for the use of conventional endoscopes and endoscopic surgical instruments
  • Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery
  • Bleeding diathesis
  • Pregnancy
  • Patients with pacemakers or internal defibrillators
  • Any planned concomitant procedures
  • Patient deprived of liberty by administrative or judicial decision
  • Participation in another interventional clinical trial
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
51 participants (actual)
Patient registry
No

Interventions

  • ProcedureCholecystectomy

    Robotic-assisted and laparoscopic cholecystectomy

06

What researchers measure

Primary outcomes

  1. primary safety endpoint

    occurrence of Clavien - Dindo grades III-V adverse events

    Time frame: up to 30 days

  2. primary performance endpoint

    successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

    Time frame: intraoperative

07

Study locations

4 sites
  • Groupe Hospitalier Saintes - Saint-Jean-d'Angély
    Saintes, 17100, France
  • Universitätsklinikum Bonn
    Bonn, 53127, Germany
  • Kantonsspital Winterthur
    Winterthur, 8401, Switzerland
  • Klinik Hirslanden Zürich
    Zurich, 8032, Switzerland
08

References and documents

Publications

  • Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multicenter study. Surg Endosc. 2025 Dec;39(12):8254-8262. doi: 10.1007/s00464-025-12174-6. Epub 2025 Sep 19. PubMed 40973903 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2024 to primary completion in Dec 2024, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2024
First posted
Jun 25, 2024
StartActual
Jun 21, 2024
Primary completionActual
Dec 30, 2024
CompletionActual
Dec 30, 2024
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Klinik Hirslanden Zürich · Zurich, Switzerland
Show 1 removed
  • Klinik Hirslanden Zürich · Zürich, Switzerland
Nov 17, 2026
Publications
Results publication added: Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multi… PubMed 40973903 ↗
Nov 17, 2026
Sponsor
Collaborators added: Confinis; collaborators removed: confinis AG
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Publications Results publication added: Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multi… PubMed 40973903 ↗
    1 site added, 1 site removed
    Show site
    • Klinik Hirslanden Zürich · Zurich, Switzerland
    Show 1 removed
    • Klinik Hirslanden Zürich · Zürich, Switzerland
    Sponsor Collaborators added: Confinis; collaborators removed: confinis AG
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06473688
Lead sponsor
Distalmotion SA
Collaborators
Confinis
Responsible party
Sponsor
First posted
Jun 25, 2024
Start date
Jun 21, 2024
Primary completion
Dec 30, 2024
Completion
Dec 30, 2024
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion